177 related articles for article (PubMed ID: 17403704)
21. [Estimating glomerular filtration rate based on serum cystatin C].
Lü RX; Li YS; Huang HJ; Peng ZY; Ying BW; An ZM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):104-7, 117. PubMed ID: 22455143
[TBL] [Abstract][Full Text] [Related]
22. Derivation and validation of cystatin C-based prediction equations for GFR in children.
Zappitelli M; Parvex P; Joseph L; Paradis G; Grey V; Lau S; Bell L
Am J Kidney Dis; 2006 Aug; 48(2):221-30. PubMed ID: 16860187
[TBL] [Abstract][Full Text] [Related]
23. Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction?
Maillard N; Mariat C; Bonneau C; Mehdi M; Thibaudin L; Laporte S; Alamartine E; Chamson A; Berthoux F
Transplantation; 2008 Jun; 85(12):1855-8. PubMed ID: 18580481
[TBL] [Abstract][Full Text] [Related]
24. Reliability of endogenous markers for estimation of residual renal function in haemodialysis patients.
Kjaergaard KD; Rehling M; Jensen JD; Jespersen B
Clin Physiol Funct Imaging; 2013 May; 33(3):224-32. PubMed ID: 23522017
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.
Tidman M; Sjöström P; Jones I
Nephrol Dial Transplant; 2008 Jan; 23(1):154-60. PubMed ID: 17911090
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children.
Cordeiro VF; Pinheiro DC; Silva GB; Lima JW; Mota RM; Libório AB; Daher EF
Clin Chim Acta; 2008 May; 391(1-2):46-50. PubMed ID: 18298952
[TBL] [Abstract][Full Text] [Related]
27. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
28. Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age.
Lankisch P; Wessalowski R; Maisonneuve P; Haghgu M; Hermsen D; Kramm CM
Pediatr Blood Cancer; 2006 Jun; 46(7):767-72. PubMed ID: 16550534
[TBL] [Abstract][Full Text] [Related]
29. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
30. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
[TBL] [Abstract][Full Text] [Related]
31. [Determination of renal function in clinical routine: which is the best method?].
Saile P; Fiedler R; Markau S; Kuhn C; Osten B
Dtsch Med Wochenschr; 2007 May; 132(20):1093-7. PubMed ID: 17492567
[TBL] [Abstract][Full Text] [Related]
32. Cystatin C and modification of diet in renal disease (MDRD) estimated glomerular filtration rate differ during normal pregnancy.
Larsson A; Palm M; Hansson LO; Axelsson O
Acta Obstet Gynecol Scand; 2010 Jul; 89(7):939-44. PubMed ID: 20334586
[TBL] [Abstract][Full Text] [Related]
33. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
34. Validation of the Virga GFR equation in a renal transplant population.
Zahran A; Hossain MA; Kora MA; Galal AZ; Shoker A
Nephron Clin Pract; 2008; 109(3):c140-7. PubMed ID: 18663326
[TBL] [Abstract][Full Text] [Related]
35. Cystatin C in critically ill patients treated with continuous venovenous hemofiltration.
Baas MC; Bouman CS; Hoek FJ; Krediet RT; Schultz MJ
Hemodial Int; 2006 Oct; 10 Suppl 2():S33-7. PubMed ID: 17022749
[TBL] [Abstract][Full Text] [Related]
36. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
[TBL] [Abstract][Full Text] [Related]
37. [Calculated renal function: benefits and problems of the "Modification of Diet in Renal Disease" (MDRD) formula].
Lhotta K; Kronenberg F; Mayer G
Dtsch Med Wochenschr; 2005 Sep; 130(36):2021-4. PubMed ID: 16143933
[No Abstract] [Full Text] [Related]
38. Cystatin C as a filtration marker--haemodialysis patients expose its strengths and limitations.
Sjöström PA; Jones IL; Tidman MA
Scand J Clin Lab Invest; 2009; 69(1):65-72. PubMed ID: 18728932
[TBL] [Abstract][Full Text] [Related]
39. [Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer].
Bodnar L; Wcisło GB; elichowski G; Raczka A; Wańkowicz Z; Szczylik C
Pol Merkur Lekarski; 2008 Apr; 24(142):307-11. PubMed ID: 18634361
[TBL] [Abstract][Full Text] [Related]
40. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
